Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q1769254> ?p ?o }
Showing triples 1 to 52 of
52
with 100 triples per page.
- Q1769254 description "Italian molecular biologist".
- Q1769254 description "Italian molecular biologist".
- Q1769254 subject Q15265373.
- Q1769254 subject Q3919876.
- Q1769254 subject Q5312304.
- Q1769254 subject Q7004365.
- Q1769254 subject Q8482041.
- Q1769254 subject Q8819169.
- Q1769254 subject Q8882890.
- Q1769254 abstract "Napoleone Ferrara, M.D. (born 26 July 1956, Catania), is an Italian-American molecular biologist who joined University of California, San Diego Moores Cancer Center in 2013 after a storied career in Northern California at the biotechnology giant Genentech, where he pioneered development of new treatments for cancer and age-related macular degeneration. There, he discovered VEGF—and made the first VEGF antibody—which suppresses growth of a variety of tumors. These findings helped lead to development of the first clinically available anti-angiogenesis inhibitor drug, bevacizumab (Avastin), which prevents the growth of new blood vessels into a solid tumor and which has become part of standard treatment for a variety of cancers. Ferrara’s work led also to the development of ranibizumab (Lucentis), a drug that is highly effective at preventing vision loss in intraocular neovascular disorders.".
- Q1769254 thumbnail Laura_Perin,_Napoleone_Ferrara,_and_Matteo_Garbelotto.jpg?width=300.
- Q1769254 wikiPageExternalLink default.aspx.
- Q1769254 wikiPageWikiLink Q1061104.
- Q1769254 wikiPageWikiLink Q1248821.
- Q1769254 wikiPageWikiLink Q15265373.
- Q1769254 wikiPageWikiLink Q180089.
- Q1769254 wikiPageWikiLink Q1903.
- Q1769254 wikiPageWikiLink Q29725.
- Q1769254 wikiPageWikiLink Q38.
- Q1769254 wikiPageWikiLink Q3919876.
- Q1769254 wikiPageWikiLink Q413299.
- Q1769254 wikiPageWikiLink Q414270.
- Q1769254 wikiPageWikiLink Q5019489.
- Q1769254 wikiPageWikiLink Q5069928.
- Q1769254 wikiPageWikiLink Q5304319.
- Q1769254 wikiPageWikiLink Q5312304.
- Q1769254 wikiPageWikiLink Q622664.
- Q1769254 wikiPageWikiLink Q7004365.
- Q1769254 wikiPageWikiLink Q8482041.
- Q1769254 wikiPageWikiLink Q8819169.
- Q1769254 wikiPageWikiLink Q8882890.
- Q1769254 wikiPageWikiLink Q899140.
- Q1769254 wikiPageWikiLink Q913404.
- Q1769254 wikiPageWikiLink Q921415.
- Q1769254 name "Ferrara, Napoleone".
- Q1769254 shortDescription "Italian molecular biologist".
- Q1769254 type Person.
- Q1769254 type Agent.
- Q1769254 type Person.
- Q1769254 type Agent.
- Q1769254 type NaturalPerson.
- Q1769254 type Thing.
- Q1769254 type Q215627.
- Q1769254 type Q5.
- Q1769254 type Person.
- Q1769254 comment "Napoleone Ferrara, M.D. (born 26 July 1956, Catania), is an Italian-American molecular biologist who joined University of California, San Diego Moores Cancer Center in 2013 after a storied career in Northern California at the biotechnology giant Genentech, where he pioneered development of new treatments for cancer and age-related macular degeneration. There, he discovered VEGF—and made the first VEGF antibody—which suppresses growth of a variety of tumors.".
- Q1769254 label "Napoleone Ferrara".
- Q1769254 depiction Laura_Perin,_Napoleone_Ferrara,_and_Matteo_Garbelotto.jpg.
- Q1769254 givenName "Napoleone".
- Q1769254 name "Ferrara, Napoleone".
- Q1769254 name "Napoleone Ferrara".
- Q1769254 surname "Ferrara".